Loading...
Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy
Antisense oligonucleotides (ASOs) have emerged as one of the most innovative new genetic drug modalities. However, their high molecular weight limits their bioavailability for otherwise-treatable neurological disorders. We investigated conjugation of ASOs to an antibody against the murine transferri...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2022
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614086/ https://ncbi.nlm.nih.gov/pubmed/36346674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.154142 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|